InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Ashley Cordova, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 17 open-market SEC Form 4 transactions: 1 purchase worth $997K and 16 sales worth $2.5M, reported from Aug 12, 21 to Sep 5, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 5, 25 | NVCRNovoCure Ltd | BUY | 81.5K | $12.22 | $997K |
| Mar 3, 25 | NVCRNovoCure Ltd | SELL | 2.1K | $18.54 | $38K |
| Feb 28, 25 | NVCRNovoCure Ltd | SELL | 2.3K | $18.28 | $43K |
| Feb 27, 25 | NVCRNovoCure Ltd | SELL | 9.3K | $20.55 | $186K |
| Aug 2, 24 | NVCRNovoCure Ltd | SELL | 688 | $20.14 | $14K |
| Sep 1, 23 | NVCRNovoCure Ltd | SELL | 883 | $21.82 | $19K |
| Aug 2, 23 | NVCRNovoCure Ltd | SELL | 1.1K | $30.25 | $35K |
| Mar 3, 23 | NVCRNovoCure Ltd | SELL | 4.7K | $76.16 | $360K |
| Mar 2, 23 | NVCRNovoCure Ltd | SELL | 1.1K | $75.28 | $79K |
| Mar 1, 23 | NVCRNovoCure Ltd | SELL | 2.2K | $76.36 | $168K |
| Sep 2, 22 | NVCRNovoCure Ltd | SELL | 885 | $79.04 | $70K |
| Mar 8, 22 | NVCRNovoCure Ltd | SELL | 759 | $70.10 | $53K |
| Mar 4, 22 | NVCRNovoCure Ltd | SELL | 556 | $70.41 | $39K |
| Mar 3, 22 | NVCRNovoCure Ltd | SELL | 1.1K | $74.50 | $86K |
| Nov 2, 21 | NVCRNovoCure Ltd | SELL | 209 | $107.28 | $22K |
| Sep 2, 21 | NVCRNovoCure Ltd | SELL | 828 | $138.23 | $114K |
| Aug 12, 21 | NVCRNovoCure Ltd | SELL | 8.0K | $141.06 | $1.1M |